2017 American Transplant Congress Archives - Page 181 of 181

Early Acute Cellular Rejection(eACR) as a Marker of Immunologic Competency Following Liver Transplantation(LT).

V. Kirchner, A. Bandgdiwala, D. Vock, M. Hassan, R. Kandaswamy, J. Lake, N. Lim, A. Mahgoub, E. Minja, A. Pugalenthi, B. Sengupta, O. Serrano, J. Thompson, W. Payne, T. Pruett, S. Chinnakotla.
Early and Late Antibody Mediated Rejection and Mixed Acute Rejection Are Clinically Distinct and Demonstrate Biologic Differences in Immunodominant Donor Specific Antibody Characteristics.

A. Lichvar,¹ E. Portwood,¹ P. Brailey,¹ S. Tremblay,¹ A. Shields,² A. Govil,¹ M. Cardi,² M. Cuffy,¹ R. Alloway,¹ A. Girnita,¹ E. Woodle.¹
Early and Late High Intrapatient Variability of Tacrolimus Levels Can Predict Late Renal Allograft Rejection.

D. Goodall, M. Willicombe, D. Swerdlow, A. McLean, D. Taube.
Early Antibody-Mediated Rejection C4d Status Remains a Marker of Prognosis in HLA-Incompatible Kidney Transplantation.

J. Malheiro,¹ S. Santos,¹ S. Tafulo,² L. Dias,¹ L. Martins,¹ J. Ramon,¹ A. Castro-Henriques.¹
Early Detection of Xenograft Rejection or Injury by Donor Derived Cell Free DNA in Pig to Baboon Cardiac Xenotransplantation.

A. Singh,¹ S. Agbor-Enoh,² J. Chan,¹ S. Groham,² P. Corcoran,¹ B. Lewis,³ M. Thomas,³ D. Ayares,⁴ K. Horvath,¹ H. Valantine,² M. Mohiuddin.¹
Early Evolution and Immunopathologic Phenotype of Treg-Rich Organized Lymphoid Structures (TOLS) Associated with Immunological Tolerance in Accepted Mouse Kidney Allografts.

C. Yang,¹ I. Rosales,² E. Farkash,³ D. Ndishabandi,^1,3 R. White,³ P. Russell,¹ J. Madsen,¹ A. Alessandrini,^1,3 R. Colvin.^1,3
Early Exposure of Everolimus with and without Calcineurin Inhibitors.

C. Felipe, A. Ferreira, T. Abait, A. Bessa, P. Ruppel, L. Hiramoto, M. Ivani, H. Tedesco, J. Medina- Pestana.
Early Failure of Kidney Transplants in the Current Era.

I. Helanterä, M. Lempinen.
Early Introduction of Oral Paricalcitol in Renal Transplant Recipients. An Open-Label Randomized Study.

H. Pihlstrøm,¹ F. Gatti,² C. Hammarstrom,² I. Eide,¹ M. Kasprzycka,² J. Wang,² G. Haraldsen,² M. Svensson,³ K. Midtvedt,¹ A. Hartmann,¹ G. Mjøen,¹ D. Dahle,¹ H. Holdaas.¹
Early Outcomes of Kidney Transplantation When Comparing Waist-to-Hip Ratio vs. Body Mass Index.

R. Patankar,¹ A. Gamilla-Crudo,¹ K. Gugliuzza,² O. Salim,³ S. Shah,¹ F. Ikram,⁴ M. Mujtaba.¹
Early Rejection in the Elderly: Is It Predictable?

J. Clark, T. Sparkes, B. Masters, S. Jonchhe, A. Haririan, B. Thomas, B. Ravichandran.
Early Results of Immune Profile Emerging Before Detection of De Novo Humoral Alloimmunity in Kidney Transplant Recipients.

J. Zimmerer, B. Ringwald, R. Pelletier, A. El-Hinnawi, A. Rajab, G. Bumgardner.
Early Results of the UK REVIVE Trial for Ex-Vivo Liver Warm Blood Perfusion of DCD and DBD Livers Using the Portable Organ Care System (OCS™) Liver Technology.

D. Vijayanand, F. Zahreldeen, J. Kingston, S. Farid, T. Mdlongwa, A. Ramsden, S. Willis, C. Moriarty, M. Attia.
Early Steroid Withdrawal and Infection in Kidney Transplant Recipients.

S. Bae, C. Durand, L. Kucirka, S. DiBrito, R. Avery, J. Garonzik Wang, D. Segev.
EBV-Specific CD8⁺ T Cells from Pediatric Thoracic vs Abdominal Transplant Recipients Are Shaped Differently by the Chronic EBV Loads with Potential Impact on the Risk of PTLD.

M. Yamada,^1,2 M. Camila,² P. Fadakar,^1,2 K. Hornor,¹ M. Michaels,^1,2 M. Green,^1,2 C. Nguyen,^1,2 B. Feingold,^1,2 G. Mazariegos,^1,2 D. Metes.²
Echinocandins in Lung Transplant Recipients (LTRs).

Y. AlJishi,¹ C. Rotstein,¹ D. Kumar,¹ A. Humar,¹ L. Singer,² S. Keshavjee,² S. Husain.¹
ECMO in Liver Transplant.

N. Goussous,^1,2 S. Hanish,¹ J. LaMattina,¹ Z. Kon,¹ D. Potosky,¹ J. Scalea,¹ W. Hutson,¹ R. Barth,¹ D. Bruno.¹
Ectopic Lymphoid Structures Are Present in Type I T-Cell Mediated Kidney Transplant Rejection.

K. de Leur,^1,2 M. Clahsen-van Groningen,³ G. de Graav,¹ D. Hesselink,¹ J. Samsom,⁴ C. Baan,¹ K. Boer.¹
Eculizumab Dose Reduction Is Safe by Monitoring Eculizumab Pre-Dose Level and Functional Complement Assays.

M. Gelens,¹ T. Havenith,² J. Damoiseaux,³ M. Christiaans.¹
Eculizumab Treatment on GC3 Recurrence on Renal Graft.

G. Jeantet,¹ D. Bertrand,³ A. Lionet,² D. Anglicheau,⁴ V. Fremeaux-Bacchi,⁵ M. Le Quintrec.¹
Educational Strategies for Increased Wait-Listing Rates: Opportunities for Dialysis Center Intervention.

A. Waterman,¹ J. Peipert,¹ H. Xiao,² C. Goalby,¹ K. Lentine.²
Effect of Academic Detailing with Prescribers as an Antimicrobial Stewardship Intervention in Solid Organ Transplant Patients.

M. So,¹ A. Morris,^1,2 C. Bell,² A. Humar,¹ S. Husain.¹
Effect of AKI Donor Admit Creatinine on Renal Transplant Outcomes.

E. Giorgakis,¹ R. Heilman,² H. Khamash,² B. Kaplan,² A. Moss,¹ M. Smith,³ K. Reddy.¹
Effect of Blood Pressure Just Before Release of the Vascular Clamps on the Renal Function of Kidney Transplantation Recipients: A Retrospective Study.

K. Tsujimura,¹ M. Ota,¹ H. Ishida,² K. Tanabe.²
Effect of Bone Marrow Derived Mesenchymal Stem Cells on Renal Ischemia-Reperfusion Injury in Rabbit.

J. Jang, H. Ri, I. Hong.
Effect of Embolization History and Tumor Treatment Response on Plasma TGFβ in HCC Patients Listed for Liver Transplantation.

P. Thevenot,¹ K. Núñez,¹ J. Gonzalez-Rosario,¹ T. Sandow,¹ A. Alharbi,¹ A. Bokhari,¹ D. Wyczechowska,² A. Ochoa,² A. Cohen.¹
Effect of Epigenetic Modifications in Ischemia-Reperfusion-Injury Post Liver Transplantation: An Integrative Approach.

D. Bagchi, S. Bontha, M. Dozmorov, A. Fernandez, V. Mas, D. Maluf.
Effect of Everolimus on the Cardiac Function in Kidney Transplant Recipients.

K. Tsujimura,¹ M. Ota,¹ H. Ishida,² K. Tanabe.²
Effect of Everolimus-Based Immunosuppressive Regimen on New Onset of Diabetes After Kidney Transplantation – A 24 Month Subanalysis from the ELEVATE Study.

H. Holdaas,¹ S. Chadban,¹ J. de Fijter,¹ L. Rostaing,¹ U. Mancilla,¹ P. Lopez,² G. Bader,² J. Cruzado,¹ M. van der Giet.¹
Effect of Everolimus-Based Regimen on Graft Outcomes in Kidney Transplant Recipients with Diabetes at Baseline: Post-Hoc Analysis from the ELEVATE Study.

J. de Fijter,¹ H. Holdaas,¹ J. Sanders,¹ S. Sundar,¹ F. Bemelman,¹ P. Lopez,² G. Bader,² J. Cruzado,¹ M. van der Giet.¹
Effect of Hepatitis C (HCV) Treatment on Rejection Incidence and Severity in Post-Liver Transplant Patients.

C. Skillin, M. Mba, B. Madani, C. Frenette.
Effect of HLA-DQ Mismatch on Efficacy Outcomes and Renal Function in Kidney Transplant Recipients: Subanalysis from the ELEVATE Study.

W. Arns,¹ J. Cruzado,¹ H. Holdaas,¹ P. Lopez,² P. Bernhardt,² G. Bader,² F. Claas,¹ M. van der Giet,¹ J. de Fijter.¹
Effect of Hypothermic Pulsatile Machine Perfusion on Kidney Delayed Graft Function in Simultaneous Liver-Kidney Transplantation: A Single Center Study.

I. Korayem,¹ H. Gritsch,² J. Veale,² G. Lipshutz,² V. Agopian,¹ F. Kaldas,¹ D. Farmer,¹ R. Busuttil,¹ A. Zarrinpar.¹
Effect of Induction Therapy in ABO Incompatible Living-Donor Kidney Transplantation: A Single Center Experience.

L. Lanfranco, L. Esposito, A. Del Bello, O. Cointault, A. Allal, L. Rostaing, N. Kamar.
Effect of Influenza Vaccination in the Severity of Illness in Hospitalized Transplant Recipients with Laboratory-Confirmed Influenza.

A. Bagenski,¹ F. Silveira.²
Effect of Initial Hepatic Arterial Followed by Portal Reperfusion on Outcomes After Liver Transplantation.

R. Shahbazov,¹ F. Azari,² J. Alejo,² M. Talanian,² M. Fox,² K. Kennedy,² S. Kessel,² A. Nickkholgh,¹ D. Maluf,¹ S. Pelletier.¹
Effect of Preformed Donor-Specific Antibodies in Intestine/Multivisceral Transplantation.

M. Safwan,¹ M. Rizzari,¹ K. Collins,¹ A. Yoshida,¹ S. Skorupski,² O. Fagoaga,² M. Abouljoud,¹ S. Nagai.¹
Effect of Statins on Influenza Vaccine Antibody Concentrations in Lung Transplant Recipients.

A. Condon,¹ C. Garmoe,² M. Hayney.²
Effect of Two Anti-CD20 Abs on B Cell Depletion and Reconstitution in Non-Human Primates.

W. Sun,¹ N. O'Neill,¹ T. Zhang,¹ G. Braileanu,¹ K. Reimann,² R. Pierson,¹ A. Azimzadeh.¹
Effective Targeting Plasma Cells with Daratumumab (Anti-CD38) and Mozobil (Anti-CXCR4) in a Sensitized Non-Human Primate Model.

J. Kwun,¹ B. Ezekian,¹ M. Manook,¹ E. Branum,¹ V. Curfman,¹ J. Park,^1,2 K. Freishlag,¹ J. Yoon,¹ S. Knechtle.¹
Effective Thrombolytic Therapy of Hepatic Artery Thrombosis After Liver Transplantation – A Single-Center Experience.

M. Chen,¹ X. Lin,² W. Ju,¹ D. Wang,¹ Y. Ma,¹ L. Wu,¹ X. He,¹ G. Chen.¹
Effects of Anti-HLA Antibodies on Endothelial Expression and Serum Levels of Thrombomodulin in Kidney Recipients.

S. Beland, O. Desy, P. Valin, S. De Serres.
Effects of Liver Transplantation on Cardiac Function in Patients Transplanted for NASH Cirrhosis.

H. Maddur, L. VanWagner, D. Gregory, B. Wodzinski, K. Maganti, M. Rinella.
Effects of New KPD Histocompatibility Policy on Refusal Rate and Transplants.

R. Leishman,¹ M. Aeder,² M. Leffell,³ C. Murphey,⁴ N. Reinsmoen,⁵ S. Saidman,⁶ T. Sandholm,⁷ A. Toll,¹ A. Harper,¹ N. Turgeon.⁸
Effects of the Gut-Liver Axis on Ischemia-Mediated Hepatocellular Carcinoma Recurrence in the Mouse Liver.

L. Orci,¹ S. Lacotte,¹ V. Delaune,¹ G. Oldani,¹ F. Slits,¹ C. Rossetti,² L. Rubbia-Brandt,³ P. Morel,¹ C. Toso.¹
Effects of Tofacitinib (JAK-3 Inhibitor) on De Novo HLA-A2 Antibody Production in a Mouse Model of Allo-Sensitization.

N.-N. Chai, G. Wu, I. Kim, A. Klein, S. Jordan.
Efficacy and Safety of ASP0113 versus Placebo in CMV-Seronegative Kidney Transplant Patients Receiving an Organ from a CMV-Seropositive Donor.

F. Vincenti,¹ K. Budde,² P. Merville,³ F. Shihab,⁴ V. Peddi,⁵ M. Shah,⁶ E. Cassuto-Viguier,⁷ A. Weidemann,^8,9 M. Lee,¹⁰ T. Flegel,¹⁰ J. Erdman,¹⁰ X. Wang,¹⁰ C. Lademacher.¹⁰
Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection.

S. Hussain, T. Taber, M. Yaqub, O. Adebiyi, D. Mishler, A. Sharfuddin.
Efficacy and Safety of Everolimus with Reduced Tacrolimus or Cyclosporine in Pediatric Liver Transplant Recipients: 12-Month Results from H2305 Study.

A. Weymann,¹ R. Ganschow,¹ B. Ericzon,¹ A. Dhawan,¹ K. Sharif,¹ E.-D. Martzloff,² B. Rauer,² J. Ng,² P. Lopez.²
Efficacy and Safety of Everolimus with Reduced-Exposure Tacrolimus and Corticosteroid Withdrawal in De Novo Pediatric Renal Transplant Recipients: 12-Month Results from the CRADLE Study.

R. Ettenger,¹ B. Tönshoff,¹ H. Tedesco,¹ L. Dello Strologo,¹ S. Marks,¹ L. Pape,¹ E. Martzloff,² B. Rauer,² J. Ng,³ P. Lopez.²
Efficacy of Calcineurin Inhibitors Transferring to Rapamycin in Live Kidney Transplantation from Old Donors to Young Recipients.

G. Chen, C. Wang, Z. Wu, C. Wang, J. Qiu, L. Chen.
Efficacy of Trimethoprim-Sulfamethoxazole Prophylaxis for Nocardia in Solid Organ Transplant Recipients (SOTRs): Systematic Review and Meta-Analysis.

A. Alsharidi,¹ A. Gonzalez,² C. Rotstein,³ A. Humar,³ D. Kumar,³ S. Husain.³
eHealth Literacy and Patient Portal Utilization Among Transplant Recipients.

K. Smith, A. Ruiz, J. Wedd, S. Pastan, R. Parker, R. Patzer.
Eight Year Follow-Up of a Phase 2 Clinical Trial to Induce Tolerance in Living Donor Renal Transplant Recipients.

J. Leventhal,¹ J. Galvin,¹ J. Mathew,¹ L. Gallon,¹ D. Stare,¹ A. Sweeney,¹ J. Miller,¹ M. Abecassis,¹ S. Ildstad.²
Eight Years of Low-Dose Valganciclovir; Evaluating the Incidence and Risk Factors of CMV in Kidney Transplant Recipients.

S. El Hajj, M. Kim, J. Azzi, S. Gabardi.
Electronic Patient Portal Functionality Among Kidney and Liver Transplant Recipients.

A. Ruiz, K. Smith, J. Wedd, K. Little, S. Pastan, R. Patzer.
Elevated Circulating AT1R Levels Indicate Heightened Risk for Antibody Mediated Rejection and Graft Failure.

P. Kimball, G. Gupta, F. McDougan.
Elevated Donor HbA1C Confers Impaired Overall Survival Following Renal Allotransplantation in Recipients of Allografts from Donors with Diabetes Mellitus: A National Analysis.

M. Mulvihill, B. Yerokun, R. Davis, A. Barbas, M. Hartwig.
Elevated Serum Lipase Levels in Simultaneous Pancreas and Kidney Transplantation May Indicate Anti-HLA Donor Specific Antibody Response.

B. Javaid, T. Raza, P. Abrams, S. Ghasemian, J. Moore, A. Gilbert, M. Grafals, J. Verbesey, M. Cooper.
Eliminating False Positive Virtual Crossmatch Results for Lung Transplant Candidates by Using Multiple Antibody Testing Platforms.

O. Timofeeva,¹ M. Kashem,² S. Geier,¹ D. Grogan,² S. Keshavamurthy,² J. Gomez-Abraham,² Y. Toyoda,² F. Cordova.²
Emergency Department Utilization Among Kidney Transplant Recipients in the United States.

B. Lovasik, R. Zhang, J. Schrager, S. Pastan, A. Adams, R. Patzer.
Emerging Application of Active Immune Targeted Delivery in Transplantation.

M. Uehara,¹ J. Azzi,¹ B. Bahmani,^1,2 J. Cheng,³ Q. Yin,³ L. Tang,³ K. Cai,³ Q. Sun,³ M. Kwon,³ Q. Xu,² G. Brandacher,⁴ R. Abdi.¹
Emerging Safety and Tolerability of Obinutuzumab, a Type 2 Anti-CD20 Monoclonal Antibody for the Desensitization of Renal Transplant Candidates.

R. Redfield,¹ S. Jordan,² T. Schindler,³ H. Tran,⁴ C. Looney,⁴ C. Green,⁴ A. Morimoto,⁴ R. Rajwanshi,⁴ M. Cascino,⁴ P. Brunetta,⁴ D. Borie.⁴
Emerging Variables Which May Enhance Care of HIV Positive Renal Transplant Recipients.

D. Leonard, M. Prendergast.
Employment Patterns After Kidney Transplantation: Rates, Contributing Factors, and Outcomes.

J. Kim, J. Rana, M. Ashwin, Y. Li, O. Famure.
Endocapillary NK Cells Are Increased in Indication Renal Transplant Biopsies with Antibody and T Cell Mediated Rejection.

A. Shammout, J. Barnes, E. Farkash.
Endoscopic Therapy of Bile Duct Strictures After Liver Transplant.

H. Woller, P. Mantry, A. Mejia, S. Cheng, C. Fasola.
Endoscopic Ultrasound Guided Biopsy Sampling of the Pancreas Transplant- The Future of Graft Surveillance?

E. Nordheim,¹ V. Paulsen,² A. Lars,² R. Horneland,³ K. Brabrand,⁴ A. Hartmann,¹ T. Jenssen.^1,5
Endovascular Management of Transplant Renal Artery Stenosis: A Safe and Effective Treatment.

A. Cavalcanti,¹ M. Durao,^1,2 B. Santos,^1,2 E. Tonato,^1,2 M. Doher,² N. Guimaraes-Souza,^1,2 L. Moreira Valle,¹ B. Affonso,¹ F. Nasser,¹ A. Pacheco-Silva.^1,2
Engaging Clinicians and Patients Regarding Frailty Assessment in Kidney Transplant Candidates.

S. Rasmussen, J. Konel, H. Ying, C. Haugen, E. King, S. DiBrito, D. Segev, M. McAdams DeMarco.
Enhanced Hepatic Engraftment of Stem Cell Derivatives Using Magnetic Targeting into Structurally Normal Liver.

N. Liu, S. Fagg, J. Fair.
Enhanced Liver Regeneration After Partial Hepatectomy in Mice Treated with a Prolyl Hydroxylase Inhibitor.

J. Latona,¹ A. Shah,¹ J. Cheng,² P. Messersmith,² E. Heber-Katz.³
Enhanced Recovery After Surgery Pathway for Living Donor Nephrectomy Patients Decreases Length of Stay and Narcotic Utilization.

R. Forbes,¹ A. King,² T. McGrane,² D. Hale,¹ W. Sandberg,² J. Wanderer,² M. McEvoy.²
Epidemiology and Clinical Outcomes of Mycobacterium tuberculosis in Liver Transplant Recipients in an Intermediate Tuberculosis-Endemic Area.

S. Kim,¹ Y. Kim,¹ J. Choi,² S. Yoon,² J. Kim,³ I. Moon,³ Y. Yoo,³ D. Kim.³
Epigenetic Modifications in the Progression to Chronic Renal Allograft Injury.

V. Bontha,¹ D. Maluf,¹ M. Dozmorov,² K. Archer,³ L. Gallon,⁴ V. Mas.¹
EPOR₂/ßcR₂-Independendent Effects of Low-Dose Epoetin-a in Porcine Liver Transplantation.

L. Kebschull,¹ F. Becker,¹ L. Theilmann,¹ B. Heitzplatz,² W. Uennigmann,¹ H. Spiegel,¹ D. Palmes.¹
EPTS Is a Poor Predictor of Post-KT Mortality for Older Recipients.

M. McAdams DeMarco, X. Luo, A. Massie, D. Segev.
ERK and HIF1 Play a Major Role in Hypothermic Protection Against Renal Ischemia-Reperfusion Injury.

K. Lee,¹ J. Jeong,² D. Choi,¹ K. Na,¹ H. Bae,¹ Y. Ham.¹
Estimating Donor Organ Quality with Baseline Histology and Kidney Donor Risk Index for Predicting Graft Outcomes in Deceased Donor Kidney Transplantation.

K. Park,¹ S. Park,² H. Park,² J. Park,¹ H. Chung,¹ M. Kim,³ H. Cho,² J. Lee.¹
Estrogen Receptor Alpha Mediates Female Protection from Renal Ischemia-Reperfusion Injury Through Mechanisms Extrinsic to the Kidney.

D. Aufhauser,¹ D. Murken,¹ Z. Wang,¹ G. Ge,¹ S. Concors,¹ T. Bhatti,² W. Hancock,^2,3 M. Levine.^1,4
Ethnicity and Transplant Knowledge Among Canadian ESKD Patients.

D. Wong,¹ H. Ford,¹ C. Lok,¹ G. Nesrallah,² J. Peipert,³ C. Richardson,¹ A. Waterman,³ M. Novak,¹ I. Mucsi.¹
Ethnocultural Barriers to Pre-Emptive Kidney Transplantation: A Single Centre Retrospective Cohort Study.

A. Bansal, M. Kwok, S. Cao, O. Famure, S. Kim, I. Mucsi.
Ethylene Carbodiimide Fixed Donor Splenocytes Combined with α-1 Antitrypsin Induce Indefinite Donor Specific Protection to Mice Cardiac Allografts.

G. Chen, X. Lai, L. Qiu, Y. Zhao, S. Yu, J. Zhang, L. Chen.
Etiology and Timing of ESRD After Kidney Donation.

A. Matas, D. Berglund, B. Sengupta, H. Ibrahim.
Evaluating Online Information on Youtube for Kidney Transplant.

P. Sheiner, S. Silver.
Evaluating Patients' Experiences Towards Their Immunosuppressive Treatment: A Way to Improve Adherence.

C. Villeneuve,^1,2 M. Grau,¹ M. Essig,^2,3 S. Hegarat,³ J. Zoughbi,³ P. Marquet,^1,2 C. Monchaud.^1,2
Evaluating T Cell Repopulation Post Alemtuzumab Induction with a Belatacept-Based Regimen.

V. Bendersky, H. Xu, A. Kirk.
Evaluation of Cytomegalovirus Prophylaxis Regimens in Intestinal Transplant Recipients: A Single Center Experience.

M. Eley,¹ M. Keck,¹ D. Collier,² M. Vacha.¹
Evaluation of Function and TCR signaling Profile of CD57⁺ T Cells in Allo-Specific Immunity.

H. Xu,¹ T. Brennan,¹ Q. Li,² A. Kirk.¹
Evaluation of Graft Functional Recovery After Simultaneously Pancreas and Kidney Transplantation with Donation After Cardiac Death in China (16 Cases of Report).

A. Hu, W. Liao, C. Zhang, X. Zhu, X. He.
Evaluation of Immunological States of Patients with Cytomegalovirus Infection After Kidney Transplantation.

A. Tanaka, K. Ide, Y. Tanaka, K. Ishiyama, M. Ohira, H. Tahara, S. Shimizu, D. Kumar, H. Ohdan.
Evaluation of Low Dose Valganciclovir for the Prevention of Cytomegalovirus in Liver Transplant Recipients.

C. Payne,¹ J. Melaragno,¹ D. Hutchinson,¹ T. Babu,² P. Prasad,^2,3 T. Dick.¹
Evaluation of Outcomes in Renal Transplantation Using Machine Perfusion for the Preservation of Kidneys from Expanded Criteria Donor.

E. Savoye, M. Macher, Kidney Working Group, C. Legeai, C. Antoine.
Evaluation of Renal Function After a Transition to Everolimus or Mycophenolate Mofetil in Liver Transplant Recipients.

C. Perez,¹ J. Fleming,¹ M. Sell,¹ B. O'brien,¹ A. Rogers,¹ I. Lee,¹ C. Mardis,¹ A. Mardis,¹ N. Patel,¹ H. Meadows,¹ N. Pilch,² K. Chavin,² D. Dubay,² R. Vinayak,² D. Taber.²
Evaluation of the Conversion from Brand Name to Generic Immunosuppression in Hospitalized Organ Transplant Recipients.

L. DeZotell,¹ K. Blunck,¹ J. Guy,¹ M. Woods,¹ M. Reffett,² J. Terrell,² A. Palermo,² K. Gosch,³ L. Cummings.⁴
Evaluation of the Enhanced Recovery After Surgery Protocol in Living Liver Donors.

A. Khalil, S. Ganesh, C. Hughes, A. Tevar, J. Hatche, S. Esper, A. Humar.
Evaluation of Vancomycin Resistant Enterococcus (VRE) Colonization and Infection Rate in Adult Liver Transplant Patients.

E. Aldag,¹ G. Fouth,¹ R. Pedersen,¹ L. Fehrenbacher,^1,2 A. Sahajpal,¹ V. Gunabushanam,¹ D. Kramer.¹
Even Non-Donor-Specific HLA-Antibodies Are Associated with a Progressive Decline in Kidney Transplant Function.

T. Mueller, K. Gerritsen, R. van Breemen, B. Ruesi, S. von Moos, P. Cippa.
Even with National Sharing, the Prospects of a 100% Sensitized Patient Receiving a Transplant Vary Dramatically Depending on the Precise CPRA Value.

D. Stewart,¹ A. Kucheryavaya,¹ D. Tyan,² H. Gebel,³ R. Bray,³ N. Turgeon.³
Everolimus Does Not Increase Risk of Delayed Graft Function or Prolong Duration of Dialysis in Renal Transplantation.

F. Shihab,¹ Y. Qazi,² S. Mulgaonkar,³ K. McCague,⁴ D. Patel,⁴ V. Peddi,⁵ D. Shaffer.⁶
Everolimus Is Associated with Less Weight Gain Than Tacrolimus Two Years Following Liver Transplantation: Results of a Randomized Multicenter Study.

M. Charlton,¹ M. Rinella,² D. Patel,³ K. McCague,³ J. Heimbach,⁴ K. Watt.⁴
Everolimus Reduces Carotid Intima-Media Thickness in Renal Transplant Recipients After One Year: Randomized Controlled Trial.

P. Garcia, H. Takase, H. Nga, M. Contti, J. Hueb, L. Morales-Buenrostro.
Evolution of CCR4highCD4+ Subpopulations in Renal Graft Blood After Steroid Withdrawal: A Prospective, Randomized, Controlled Study in Parallel Groups. Preliminary Results.

J. Alonso-Titos,¹ P. Ruiz-Esteban,¹ E. Palma,¹ A. Caballero,² E. Sola,¹ M. Cabello,¹ T. Vazquez,¹ A. Duarte,¹ C. Jironda,¹ D. Hernandez.¹
Evolution of Health Related Quality of Life (HRQOL) in Kidney Donors.

H. Ibrahim,¹ D. Berglund,¹ S. Jackson,² A. Matas.¹
Evolution of Lipid Profile and Major Adverse Cardiac Events in Kidney Transplant Recipients Converted from Calcineurin Inhibitor to Everolimus: 24-Month Subanalysis from Elevate Study.

M. van der Giet,¹ J. de Fijter,¹ F. Oppenheimer,¹ G. Russ,¹ P. Lopez,² G. Bader,² J. Cruzado,¹ H. Holdaas.¹
Ex vivo Expanded Regulatory T cells Combined with Short-Term Costimulation Blockade Prevent Rejection of Vascularized Composite Allografts.

B. Oh, G. Furtmüller, M. Iglesias, M. Fryer, P. Akre, D. Cooney, W. Lee, G. Raimondi, G. Brandacher.
Ex-Situ Extended Limb Preservation: A Protocol for Porcine Limb Perfusion.

E. Dalla Pozza,¹ E. Duraes,¹ M. Madajka,¹ R. Frautschi,¹ K. Cho,¹ N. Dawlagala,¹ V. Fahradyan,¹ H. Shah,¹ C. Cakmakoglu,¹ C. Quintini,² F. Papay,¹ A. Rampazzo,¹ B. Bassiri Gharb.¹
Ex-Vivo Mitomycin-C Exposure Reduced Immunogenicity and Prolonged Survival of Islets by Suppressing the Secretion of Multiple Chemotaxis Factors.

N. Sato,¹ T. Anazawa,² A. Kenjyo,¹ T. Kimura,¹ R. Okada,¹ T. Ishigame,¹ Y. Kofunato,¹ J. Watanabe,¹ M. Muto,¹ A. Nishimagi,¹ M. Gotoh,¹ S. Marubashi.¹
Exception Scores for Patients on the Liver Waiting List.

T. Weaver,¹ D. Schladt,¹ M. Skeans,¹ J. Pyke,¹ J. Zeglin,¹ S. Leppke,¹ A. Israni,^1,2 B. Kasiske,^1,2 W. Kim,³ J. Lake.⁴
Exceptions Points and Size Drive Gender Disparities in Liver Transplantation.

L. Nephew,¹ D. Goldberg,^1,2 J. Lewis,^1,2 P. Abt,³ M. Bryan,⁴ K. Forde.^1,2
Exosomes Containing IL35 Are Secreted by Donor-Specific Regulatory T Cells and Cause Linked-Suppression.

Y. Tomita,¹ W. Bracamonte-Baran,¹ E. Jankowska-Gan,¹ Q. Zhang,² D. Vignali,² W. Burlingham.¹
Expanded Criteria for HCC in Liver Transplantation.

M. Haberal,¹ A. Akdur,¹ G. Moray,¹ G. Arslan,² F. Ozcay,³ H. Selcuk,⁴ H. Ozdemir.⁵
EXPANDER-1: Exploring Renal Transplants Using Hepatitis-C Infected Donors for HCV-Negative Recipients.

C. Durand, D. Brown, R. Wesson, N. Bhair, F. Naqvi, D. Ostrander, M. Bowring, A. Massie, S. Rasmussen, J. Sugarman, D. Segev, M. Sulkowski, N. Desai.
Expansion, Function and Clonotypic Analysis of Human Alloreactive Treg Stimulated with Different Dendritic Cell Populations or CD40L-Stimulated B Cells.

H. Zhang,¹ Y. Zhao,¹ Q. Tang,³ A. Thomson.^1,2
Expectations and Experiences of Follow-Up and Self-Care After Living Kidney Donation: A Focus Group Study.

K. Manera,^1,2 C. Hanson,^1,2 J. Chapman,³ J. Kanellis,^4,5 J. Gill,⁶ J. Craig,^1,2 S. Chadban,^7,8 G. Wong,^1,2,3 A. Ralph,^1,2 A. Tong.^1,2
Experience with Belatacept (CTLA4-Ig) Conversion in Highly HLA Sensitized (HS) and ABO-Incompatible (ABOi) Patients Who Received Incompatible Kidney Transplants Post Desensitization (DES).

J. Choi,¹ A. Peng,¹ A. Vo,¹ E. Huang,¹ R. Najjar,¹ S. Louie,¹ A. Kang,¹ S. Ge,¹ M. Toyoda,¹ X. Zhang,² S. Jordan.¹
Experience with Obinutuzumab (Type II Anti-CD20) in Kidney Transplant Patients with Donor Specific Antibody (DSA+) Antibody Mediated Rejection.

J. Choi, A. Vo, E. Huang, S. Louie, A. Kang, A. Peng, R. Najjar, S. Jordan.
Experience with the Bacterial Enzyme IdeS (IgG Endopeptidase) for Desensitization of Highly-HLA Sensitized (HS) Kidney Allograft Recipients.

S. Jordan,¹ J. Choi,¹ C. Kjellman,² L. Winstedt,² X. Zhang,⁴ S. Louie,¹ A. Kang,¹ M. Haas,³ A. Vo.¹
Experimental Study of Hepatocyte Proliferation Regulated by miR26a.

J. Zhou, X. Yuan, W. Ju, X. Jiao, D. Wang, X. Zhu, X. He.
Exploring Differential Antibody Response to Bortezomib in Heart Transplantation.

K. Ghafourian, R. Hod-Dvorai, S. McCabe, N. Cool, M. Fine, M. Ackerman, J. Rich, J. Wilcox, E. Vorovich, A. Anderson, A. Tambur.
Expression of Injury and Repair Genes in Ex Vivo Perfused Swing Lung Transplants.

P. Dromparis,¹ S. Wagner,¹ N. Aboelnaz,² J. Luc,² D. Freed,² J. Nagendran,² M. Mengel,¹ B. Adam.¹
Expression of T-Cell Mediated Rejection (TCMR) Associated Genes in Native and Renal Allograft Renal Biopsies with Inflamed Scars (i-IFTA).

Z. Lyu,¹ L. Pang,¹ G. Zeng,² Y. Huang,² P. Randhawa.²
Extended Ex Vivo Kidney Perfusion Using Hemopure as an Oxygen Carrier: A Method to Preserve, Assess and Repair Discarded Organs.

F. Fontan, M. Aburawi, N. Karimian, K. Uygun, F. Delmonico, H. Yeh, J. Markmann.
Extended Experience with Tocilizumab (Anti-IL6R) for Difficult to Desensitize (Des) Patients Awaiting HLA Incompatible Kidney Transplant.

A. Vo, J. Choi, I. Kim, E. Huang, S. Louie, A. Kang, S. Williamson, K. Myers, A. Peng, R. Najjar, S. Jordan.
Extending the Limit for Living Donor Liver Transplantation: Similar Outcomes After Left vs. Right Lobe Graft, a Propensity Score Analysis.

T. Wong, K. Ng, J. Fung, K. Chok, A. Chan, C. Lo.
Extra-Renal Cardiac Injury Is Associated with Upregulation of NOD2 and Nlrp3 in the Heart After Renal IRI.

A. Scheinok, S. Kasimsetty, E. Soo, C. Nelson, A. Shigeoka, D. McKay.
Extracellular Mitochondria Cause B7 Costimulation Blockade Resistant Allograft Rejection in Mice.

T. Brennan,¹ L. Lin,¹ M. Song,¹ F. Feng,¹ Q.-J. Li,² A. Kirk,^1,2 H. Xu.¹
Extraction Time During Liver Retrieval Impairs Survival After Transplantation.

I. Jochmans,¹ S. Fieuws,² I. Tieken,³ U. Samuel,³ J. Pirenne.¹